BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9973454)

  • 1. Cutting edge: chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF- plus IFN-gamma-producing CD4+ T cells that respond to bacterial antigens.
    Wirtz S; Finotto S; Kanzler S; Lohse AW; Blessing M; Lehr HA; Galle PR; Neurath MF
    J Immunol; 1999 Feb; 162(4):1884-8. PubMed ID: 9973454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype.
    Claesson MH; Bregenholt S; Bonhagen K; Thoma S; Möller P; Grusby MJ; Leithäuser F; Nissen MH; Reimann J
    J Immunol; 1999 Mar; 162(6):3702-10. PubMed ID: 10092833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of intestinal bacteria on induction of regulatory T cells: lessons from a transfer model of colitis.
    Strauch UG; Obermeier F; Grunwald N; Gürster S; Dunger N; Schultz M; Griese DP; Mähler M; Schölmerich J; Rath HC
    Gut; 2005 Nov; 54(11):1546-52. PubMed ID: 15987795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T cell-associated CD18 but not CD62L, ICAM-1, or PSGL-1 is required for the induction of chronic colitis.
    Ostanin DV; Furr KL; Pavlick KP; Gray L; Kevil CG; Shukla D; D'Souza D; Hoffman JM; Grisham MB
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1706-14. PubMed ID: 17332469
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monoclonal anti-interleukin 23 reverses active colitis in a T cell-mediated model in mice.
    Elson CO; Cong Y; Weaver CT; Schoeb TR; McClanahan TK; Fick RB; Kastelein RA
    Gastroenterology; 2007 Jun; 132(7):2359-70. PubMed ID: 17570211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
    Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M
    Gastroenterology; 2007 Jan; 132(1):176-89. PubMed ID: 17241870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunosenescent colitogenic CD4(+) T cells convert to regulatory cells and suppress colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Tsuchiya K; Sakamoto N; Okamoto R; Watanabe M
    Eur J Immunol; 2008 May; 38(5):1275-86. PubMed ID: 18412161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD69 regulates type I IFN-induced tolerogenic signals to mucosal CD4 T cells that attenuate their colitogenic potential.
    Radulovic K; Manta C; Rossini V; Holzmann K; Kestler HA; Wegenka UM; Nakayama T; Niess JH
    J Immunol; 2012 Feb; 188(4):2001-13. PubMed ID: 22250092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RANK-RANKL signaling pathway is critically involved in the function of CD4+CD25+ regulatory T cells in chronic colitis.
    Totsuka T; Kanai T; Nemoto Y; Tomita T; Okamoto R; Tsuchiya K; Nakamura T; Sakamoto N; Akiba H; Okumura K; Yagita H; Watanabe M
    J Immunol; 2009 May; 182(10):6079-87. PubMed ID: 19414759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyclonal expansion of adoptively transferred CD4+ alpha beta T cells in the colonic lamina propria of scid mice with colitis.
    Rudolphi A; Bonhagen K; Reimann J
    Eur J Immunol; 1996 May; 26(5):1156-63. PubMed ID: 8647181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.
    Afkarian M; Sedy JR; Yang J; Jacobson NG; Cereb N; Yang SY; Murphy TL; Murphy KM
    Nat Immunol; 2002 Jun; 3(6):549-57. PubMed ID: 12006974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis.
    Ito Y; Kanai T; Totsuka T; Okamoto R; Tsuchiya K; Nemoto Y; Yoshioka A; Tomita T; Nagaishi T; Sakamoto N; Sakanishi T; Okumura K; Yagita H; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G199-207. PubMed ID: 17962357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-receptor 2 is up-regulated on lamina propria T cells in Crohn's disease and promotes experimental colitis in vivo.
    Holtmann MH; Douni E; Schütz M; Zeller G; Mudter J; Lehr HA; Gerspach J; Scheurich P; Galle PR; Kollias G; Neurath MF
    Eur J Immunol; 2002 Nov; 32(11):3142-51. PubMed ID: 12555659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IL-7 is essential for lymphopenia-driven turnover of colitogenic CD4(+) memory T cells in chronic colitis.
    Tomita T; Kanai T; Totsuka T; Nemoto Y; Okamoto R; Tsuchiya K; Sakamoto N; Ohteki T; Hibi T; Watanabe M
    Eur J Immunol; 2009 Oct; 39(10):2737-47. PubMed ID: 19637223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ameliorating effect of anti-Fas ligand MAb on wasting disease in murine model of chronic colitis.
    Dan N; Kanai T; Totsuka T; Iiyama R; Yamazaki M; Sawada T; Miyata T; Yagita H; Okumura K; Watanabe M
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G754-60. PubMed ID: 12969829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IL-12, independently of IFN-gamma, plays a crucial role in the pathogenesis of a murine psoriasis-like skin disorder.
    Hong K; Chu A; Lúdvíksson BR; Berg EL; Ehrhardt RO
    J Immunol; 1999 Jun; 162(12):7480-91. PubMed ID: 10358203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Constitutive expression of CIITA directs CD4 T cells to produce Th2 cytokines in the thymus.
    Patel DR; Li W; Park JS; Sofi MH; Gourley TS; Hangoc G; Kaplan MH; Chang CH
    Cell Immunol; 2005 Jan; 233(1):30-40. PubMed ID: 15876426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Administration of mAb against alpha E beta 7 prevents and ameliorates immunization-induced colitis in IL-2-/- mice.
    Lúdvíksson BR; Strober W; Nishikomori R; Hasan SK; Ehrhardt RO
    J Immunol; 1999 Apr; 162(8):4975-82. PubMed ID: 10202045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of intestinal lymphocytes in mouse colitis mediated by transfer of CD4+, CD45RBhigh T cells to SCID recipients.
    Aranda R; Sydora BC; McAllister PL; Binder SW; Yang HY; Targan SR; Kronenberg M
    J Immunol; 1997 Apr; 158(7):3464-73. PubMed ID: 9120308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.